Skip to main content
ASND logo
ASND
(NASDAQ)
Ascendis Pharma A/S
$230.83-- (--)
Loading... - Market loading

Ascendis Pharma A/S (ASND) Stock Price & Financial Analysis

Ascendis Pharma A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$230.23 - $237.00
52-Week High$250.74
52-Week Low$160.86
Open$233.60
Volume891.71K
Average Volume (3M)625.04K
Market Cap14.89B
Shares Outstanding64.52M
P/E Ratio (TTM)25.64
Price to Sales (P/S)14.92
Price to Book (P/B)26.57
EV/EBITDA-221.97
Revenue (TTM)998.09M
Net Income (TTM)580.93M
Free Cash Flow (TTM)51.34M
EPS (TTM)$9.29
Profit Margin58.20%
Operating Margin-1.18%
Return on Equity (ROE)103.64%
Debt to Equity1.84
50-Day MA$231.76
200-Day MA$217.83
52-Week Change35.22%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Ascendis Pharma A/S

What is the current stock price for ASND?

As of the latest trading session, ASND stock trades at $230.83. The 52-week range is $160.86–$250.74, with a day range of $230.23–$237.00.

What is the P/E ratio for ASND?

Ascendis Pharma A/S's trailing P/E ratio is 25.6, meaning investors pay $25.6 for every $1 of annual earnings. Ascendis Pharma A/S operates in the Healthcare sector.

Does ASND pay dividends?

Ascendis Pharma A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ASND?

Based on 14 analysts, the consensus for ASND is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ASND?

Ascendis Pharma A/S's market capitalization is $14.89B, classifying it as a large-cap company. Ascendis Pharma A/S operates in the Healthcare sector within the Biotechnology industry.